Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Lumen Technologies Completes $1.08 Billion in Debt Exchange

Lumen Technologies and its subsidiary Qwest Corporation said the exchange offers for two long-dated note series have expired, with investors tendering more than $1.08 billion of debt for replacement securities.

For the 6.5% notes due 2056, Qwest had $977.5 million outstanding before the offer and accepted $831.9 million in principal for exchange. That total split between $515.3 million of new 6.500% notes due 2051 in $25 denominations and $316.6 million of the same new notes in $1 denominations. Holders of that series will also receive $2.08 million in cash tied to the consent solicitation fee.

For the 6.75% notes due 2057, Qwest had $660.0 million outstanding and accepted $551.9 million for exchange. Of that amount, $381.5 million will be issued as new 6.750% notes due 2052 in $25 denominations, while $170.4 million will be issued as new 6.500% notes due 2051 in $1 denominations. Cash paid for consents on that series totals $1.38 million.

Across both note series, Qwest accepted $1.384 billion of old notes and will issue the same amount of new notes in principal value, plus $3.46 million in cash for consent fees.

The company said the new notes are expected to be delivered on June 11, 2026. Qwest also said it received the required majority consents for amendments to both old indentures, and the supplemental indentures will take effect on the settlement date. Following these announcements, the company's shares moved -1.83%, and are now trading at a price of $8.315. For the full picture, make sure to review Lumen Technologies's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS